205 related articles for article (PubMed ID: 31527690)
1. Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause.
Ibáñez-Sanz G; Díez-Villanueva A; Riera-Ponsati M; Fernández-Villa T; Fernández Navarro P; Bustamante M; Llorca J; Amiano P; Ascunce N; Fernández-Tardón G; Salcedo Bellido I; Salas D; Capelo Álvarez R; Crous-Bou M; Ortega-Valín L; Pérez-Gómez B; Castaño-Vinyals G; Palazuelos C; Altzibar JM; Ardanaz E; Tardón A; Jiménez Moleón JJ; Olmos Juste V; Aragonés N; Pollán M; Kogevinas M; Moreno V
Sci Rep; 2019 Sep; 9(1):13407. PubMed ID: 31527690
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
Rodriguez-Broadbent H; Law PJ; Sud A; Palin K; Tuupanen S; Gylfe A; Hänninen UA; Cajuso T; Tanskanen T; Kondelin J; Kaasinen E; Sarin AP; Ripatti S; Eriksson JG; Rissanen H; Knekt P; Pukkala E; Jousilahti P; Salomaa V; Palotie A; Renkonen-Sinisalo L; Lepistö A; Böhm J; Mecklin JP; Al-Tassan NA; Palles C; Martin L; Barclay E; Farrington SM; Timofeeva MN; Meyer BF; Wakil SM; Campbell H; Smith CG; Idziaszczyk S; Maughan TS; Kaplan R; Kerr R; Kerr D; Passarelli MN; Figueiredo JC; Buchanan DD; Win AK; Hopper JL; Jenkins MA; Lindor NM; Newcomb PA; Gallinger S; Conti D; Schumacher F; Casey G; Aaltonen LA; Cheadle JP; Tomlinson IP; Dunlop MG; Houlston RS
Int J Cancer; 2017 Jun; 140(12):2701-2708. PubMed ID: 28340513
[TBL] [Abstract][Full Text] [Related]
3. Blood Lipids and the Risk of Colorectal Cancer: Mendelian Randomization Analyses in the Japanese Consortium of Genetic Epidemiology Studies.
Iwagami M; Goto A; Katagiri R; Sutoh Y; Koyanagi YN; Nakatochi M; Nakano S; Hanyuda A; Narita A; Shimizu A; Tanno K; Hozawa A; Kinoshita K; Oze I; Ito H; Yamaji T; Sawada N; Nakamura Y; Nakamura S; Kuriki K; Suzuki S; Hishida A; Kasugai Y; Imoto I; Suzuki M; Momozawa Y; Takeuchi K; Yamamoto M; Sasaki M; Matsuo K; Tsugane S; Wakai K; Iwasaki M
Cancer Prev Res (Phila); 2022 Dec; 15(12):827-836. PubMed ID: 36040498
[TBL] [Abstract][Full Text] [Related]
4. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
5. Blood lipids and prostate cancer: a Mendelian randomization analysis.
Bull CJ; Bonilla C; Holly JM; Perks CM; Davies N; Haycock P; Yu OH; Richards JB; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; MacInnis RJ; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Micheal A; Pandha H; Smith GD; Lewis SJ; Martin RM;
Cancer Med; 2016 Jun; 5(6):1125-36. PubMed ID: 26992435
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study.
Weng LC; Roetker NS; Lutsey PL; Alonso A; Guan W; Pankow JS; Folsom AR; Steffen LM; Pankratz N; Tang W
PLoS One; 2018; 13(4):e0195719. PubMed ID: 29649275
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis.
Proitsi P; Lupton MK; Velayudhan L; Newhouse S; Fogh I; Tsolaki M; Daniilidou M; Pritchard M; Kloszewska I; Soininen H; Mecocci P; Vellas B; ; Williams J; ; Stewart R; Sham P; Lovestone S; Powell JF
PLoS Med; 2014 Sep; 11(9):e1001713. PubMed ID: 25226301
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia and Risk of Preeclampsia: A Multiancestry Mendelian Randomization Study.
Hosier H; Lipkind HS; Rasheed H; DeWan AT; Rogne T
Hypertension; 2023 May; 80(5):1067-1076. PubMed ID: 36883459
[TBL] [Abstract][Full Text] [Related]
9. Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization.
Passarelli MN; Newcomb PA; Makar KW; Burnett-Hartman AN; Potter JD; Upton MP; Zhu LC; Rosenfeld ME; Schwartz SM; Rutter CM
Cancer Causes Control; 2015 Mar; 26(3):467-73. PubMed ID: 25618792
[TBL] [Abstract][Full Text] [Related]
10. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies.
Nimptsch K; Song M; Aleksandrova K; Katsoulis M; Freisling H; Jenab M; Gunter MJ; Tsilidis KK; Weiderpass E; Bueno-De-Mesquita HB; Chong DQ; Jensen MK; Wu C; Overvad K; Kühn T; Barrdahl M; Melander O; Jirström K; Peeters PH; Sieri S; Panico S; Cross AJ; Riboli E; Van Guelpen B; Myte R; Huerta JM; Rodriguez-Barranco M; Quirós JR; Dorronsoro M; Tjønneland A; Olsen A; Travis R; Boutron-Ruault MC; Carbonnel F; Severi G; Bonet C; Palli D; Janke J; Lee YA; Boeing H; Giovannucci EL; Ogino S; Fuchs CS; Rimm E; Wu K; Chan AT; Pischon T
Eur J Epidemiol; 2017 May; 32(5):419-430. PubMed ID: 28550647
[TBL] [Abstract][Full Text] [Related]
12. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
[TBL] [Abstract][Full Text] [Related]
13. Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: A Mendelian randomization study.
Ma Y; Jian Z; Xiang L; Jin X
Int J Cancer; 2022 Aug; 151(4):518-525. PubMed ID: 35429337
[TBL] [Abstract][Full Text] [Related]
14. Causal effects of plasma lipids on the risk of atrial fibrillation: A multivariable mendelian randomization study.
Jiang Q; Qin D; Yang L; Lin Y; Zhai L; Zhang Y; Yang G; Wang K; Tong D; Li X; Chen Z; Huang K; Yu T; Xiang X; Cui C; Cai C; Shi J; Li M; Chen M
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1569-1578. PubMed ID: 33814236
[TBL] [Abstract][Full Text] [Related]
15. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
Nimptsch K; Aleksandrova K; Pham TT; Papadimitriou N; Janke J; Christakoudi S; Heath A; Olsen A; Tjønneland A; Schulze MB; Katzke V; Kaaks R; van Guelpen B; Harbs J; Palli D; Macciotta A; Pasanisi F; Yohar SMC; Guevara M; Amiano P; Grioni S; Jakszyn PG; Figueiredo JC; Samadder NJ; Li CI; Moreno V; Potter JD; Schoen RE; Um CY; Weiderpass E; Jenab M; Gunter MJ; Pischon T
BMC Med; 2023 Oct; 21(1):391. PubMed ID: 37833736
[TBL] [Abstract][Full Text] [Related]
16. Are blood lipids risk factors for fracture? Integrative evidence from instrumental variable causal inference and mediation analysis using genetic data.
Chen H; Shao Z; Gao Y; Yu X; Huang S; Zeng P
Bone; 2020 Feb; 131():115174. PubMed ID: 31785374
[TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.
Wang X; Dai JY; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Buchanan DD; Butterbach K; Caan B; Casey G; Campbell PT; Chan AT; Chen Z; Chang-Claude J; Cotterchio M; Easton DF; Giles GG; Giovannucci E; Grady WM; Hoffmeister M; Hopper JL; Hsu L; Jenkins MA; Joshi AD; Lampe JW; Larsson SC; Lejbkowicz F; Li L; Lindblom A; Le Marchand L; Martin V; Milne RL; Moreno V; Newcomb PA; Offitt K; Ogino S; Pharoah PDP; Pinchev M; Potter JD; Rennert HS; Rennert G; Saliba W; Schafmayer C; Schoen RE; Schrotz-King P; Slattery ML; Song M; Stegmaier C; Weinstein SJ; Wolk A; Woods MO; Wu AH; Gruber SB; Peters U; White E
Int J Epidemiol; 2019 Jun; 48(3):767-780. PubMed ID: 30476131
[TBL] [Abstract][Full Text] [Related]
18. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study.
Han X; Ong JS; Hewitt AW; Gharahkhani P; MacGregor S
Int J Epidemiol; 2021 Mar; 50(1):325-336. PubMed ID: 33211829
[TBL] [Abstract][Full Text] [Related]
19. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis.
Tian Y; Wang K; Li J; Wang J; Wang Z; Fan Y; Ye Y; Ji G; Li Y
Public Health Nutr; 2015 Dec; 18(18):3355-70. PubMed ID: 25776573
[TBL] [Abstract][Full Text] [Related]
20. Identifying metabolic features of colorectal cancer liability using Mendelian randomization.
Bull C; Hazelwood E; Bell JA; Tan V; Constantinescu AE; Borges C; Legge D; Burrows K; Huyghe JR; Brenner H; Castellvi-Bel S; Chan AT; Kweon SS; Le Marchand L; Li L; Cheng I; Pai RK; Figueiredo JC; Murphy N; Gunter MJ; Timpson NJ; Vincent EE
Elife; 2023 Dec; 12():. PubMed ID: 38127078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
